16-81889208-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002661.5(PLCG2):​c.802C>T​(p.Arg268Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.057 in 1,602,822 control chromosomes in the GnomAD database, including 3,082 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R268Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.046 ( 210 hom., cov: 31)
Exomes 𝑓: 0.058 ( 2872 hom. )

Consequence

PLCG2
NM_002661.5 missense

Scores

1
4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.789
Variant links:
Genes affected
PLCG2 (HGNC:9066): (phospholipase C gamma 2) The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027187467).
BP6
Variant 16-81889208-C-T is Benign according to our data. Variant chr16-81889208-C-T is described in ClinVar as [Benign]. Clinvar id is 403319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81889208-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0666 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCG2NM_002661.5 linkc.802C>T p.Arg268Trp missense_variant Exon 10 of 33 ENST00000564138.6 NP_002652.2 P16885
PLCG2NM_001425749.1 linkc.802C>T p.Arg268Trp missense_variant Exon 11 of 34 NP_001412678.1
PLCG2NM_001425750.1 linkc.802C>T p.Arg268Trp missense_variant Exon 10 of 33 NP_001412679.1
PLCG2NM_001425751.1 linkc.802C>T p.Arg268Trp missense_variant Exon 11 of 34 NP_001412680.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCG2ENST00000564138.6 linkc.802C>T p.Arg268Trp missense_variant Exon 10 of 33 1 NM_002661.5 ENSP00000482457.1 P16885

Frequencies

GnomAD3 genomes
AF:
0.0458
AC:
6836
AN:
149408
Hom.:
210
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0111
Gnomad AMI
AF:
0.0658
Gnomad AMR
AF:
0.0444
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0171
Gnomad FIN
AF:
0.0487
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0682
Gnomad OTH
AF:
0.0515
GnomAD2 exomes
AF:
0.0465
AC:
11244
AN:
242006
AF XY:
0.0470
show subpopulations
Gnomad AFR exome
AF:
0.00950
Gnomad AMR exome
AF:
0.0327
Gnomad ASJ exome
AF:
0.101
Gnomad EAS exome
AF:
0.000112
Gnomad FIN exome
AF:
0.0502
Gnomad NFE exome
AF:
0.0652
Gnomad OTH exome
AF:
0.0544
GnomAD4 exome
AF:
0.0581
AC:
84487
AN:
1453296
Hom.:
2872
Cov.:
29
AF XY:
0.0576
AC XY:
41625
AN XY:
722636
show subpopulations
Gnomad4 AFR exome
AF:
0.0101
AC:
337
AN:
33400
Gnomad4 AMR exome
AF:
0.0351
AC:
1554
AN:
44240
Gnomad4 ASJ exome
AF:
0.104
AC:
2704
AN:
25906
Gnomad4 EAS exome
AF:
0.000126
AC:
5
AN:
39658
Gnomad4 SAS exome
AF:
0.0159
AC:
1350
AN:
84918
Gnomad4 FIN exome
AF:
0.0511
AC:
2719
AN:
53166
Gnomad4 NFE exome
AF:
0.0652
AC:
72101
AN:
1106136
Gnomad4 Remaining exome
AF:
0.0566
AC:
3404
AN:
60124
Heterozygous variant carriers
0
3259
6518
9778
13037
16296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2554
5108
7662
10216
12770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0457
AC:
6834
AN:
149526
Hom.:
210
Cov.:
31
AF XY:
0.0441
AC XY:
3210
AN XY:
72788
show subpopulations
Gnomad4 AFR
AF:
0.0111
AC:
0.0110887
AN:
0.0110887
Gnomad4 AMR
AF:
0.0444
AC:
0.0443707
AN:
0.0443707
Gnomad4 ASJ
AF:
0.103
AC:
0.103239
AN:
0.103239
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.0172
AC:
0.0171635
AN:
0.0171635
Gnomad4 FIN
AF:
0.0487
AC:
0.048721
AN:
0.048721
Gnomad4 NFE
AF:
0.0682
AC:
0.0682403
AN:
0.0682403
Gnomad4 OTH
AF:
0.0510
AC:
0.0509709
AN:
0.0509709
Heterozygous variant carriers
0
281
562
844
1125
1406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0616
Hom.:
1406
Bravo
AF:
0.0454
TwinsUK
AF:
0.0696
AC:
258
ALSPAC
AF:
0.0618
AC:
238
ESP6500AA
AF:
0.0115
AC:
46
ESP6500EA
AF:
0.0694
AC:
580
ExAC
AF:
0.0445
AC:
5386
Asia WGS
AF:
0.00895
AC:
31
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Familial cold autoinflammatory syndrome 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.45
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.30
T;.
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.83
T;T
MetaRNN
Benign
0.0027
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;.
PrimateAI
Benign
0.46
T
PROVEAN
Benign
0.98
.;N
REVEL
Benign
0.15
Sift
Benign
0.030
.;D
Sift4G
Uncertain
0.041
D;D
Polyphen
0.99
D;.
Vest4
0.39
MPC
0.34
ClinPred
0.025
T
GERP RS
2.8
Varity_R
0.15
gMVP
0.72
Mutation Taster
=84/16
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1143687; hg19: chr16-81922813; COSMIC: COSV63873174; COSMIC: COSV63873174; API